AGIO:NASDAQ
Agios Pharmaceuticals Inc
$33.08
arrow_downward
-0.17%(-0.055) 1D
Sep 4, 2:38:24 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$33.13
High
$33.50
Low
$33.00
Mkt. cap
1.97B
Avg. vol.
1.08M
Volume
157.89K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.60
Shares outstanding
59.70M
No. of employees
540
Open
$33.13
High
$33.50
Low
$33.00
Mkt. cap
1.97B
Avg. vol.
1.08M
Volume
157.89K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.60
Shares outstanding
59.70M
No. of employees
540
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 week ago
AGIO Q2 2026 Earnings: Narrower-Than-Expected Loss Fails to Halt Share Decline - Profit Recovery Report
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc